Cyfuse Biomedical Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Public

  • Employees
  • 22

Employees

  • Stock Symbol
  • 4892

Stock Symbol

  • Share Price
  • $4.61
  • (As of Tuesday Closing)

Cyfuse Biomedical General Information

Description

Cyfuse Biomedical KK is engaged in the development, manufacturing, and sales of regenerative medicine related products.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • 1F Sumitomo Real Estate Mita Twin Building West Wing
  • 3-5-27 Mita, Minato-ku
  • Tokyo, 108-6301
  • Japan
+81
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Stock Exchange
TKS
Vertical(s)
Corporate Office
  • 1F Sumitomo Real Estate Mita Twin Building West Wing
  • 3-5-27 Mita, Minato-ku
  • Tokyo, 108-6301
  • Japan
+81

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cyfuse Biomedical Stock Performance

As of 15-Jul-2025, Cyfuse Biomedical’s stock price is $4.61. Its current market cap is $38.3M with 8.3M shares.

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.61 $4.77 $2.75 - $9.36 $38.3M 8.3M 151K -$0.72

Cyfuse Biomedical Financials Summary

As of 31-Dec-2024, Cyfuse Biomedical has a trailing 12-month revenue of $360K.

In Thousands,
USD
TTM 31-Dec-2024 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022
EV 7,362 7,362 21,876 57,308
Revenue 360 360 435 2,850
EBITDA (5,445) (5,445) (3,831) (2,966)
Net Income (5,759) (5,759) (4,193) (3,607)
Total Assets 22,403 22,403 29,886 36,725
Total Debt 5,431 5,431 6,474 6,926
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Cyfuse Biomedical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cyfuse Biomedical‘s full profile, request access.

Request a free trial

Cyfuse Biomedical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Cyfuse Biomedical KK is engaged in the development, manufacturing, and sales of regenerative medicine related products.
Discovery Tools (Healthcare)
Tokyo, Japan
22 As of 2024

Basel, Switzerland
 

Bridgewater, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cyfuse Biomedical Competitors (8)

One of Cyfuse Biomedical’s 8 competitors is Lonza Group, a Corporation company based in Basel, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Lonza Group Corporation Basel, Switzerland
3D Biotek Corporate Backed or Acquired Bridgewater, NJ
Sutro Biopharma Formerly VC-backed South San Francisco, CA
Teva Pharmaceutical Industries Corporation Tel Aviv, Israel
Aspect Biosystems Venture Capital-Backed Vancouver, Canada
You’re viewing 5 of 8 competitors. Get the full list »

Cyfuse Biomedical Patents

Cyfuse Biomedical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2024156287-A Angle adjustment mechanism and puncture device Pending 24-Apr-2023
JP-2024151045-A Dispensing device Pending 11-Apr-2023
JP-2024143092-A Tray holding mechanism Pending 30-Mar-2023
EP-4428811-A1 Fibrosis evaluation method for biological sample Pending 10-Mar-2023
JP-2024128350-A Fibrosis evaluation method for biological sample Pending 10-Mar-2023 G06T7/0012
To view Cyfuse Biomedical’s complete patent history, request access »

Cyfuse Biomedical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cyfuse Biomedical Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cyfuse Biomedical‘s full profile, request access.

Request a free trial

Cyfuse Biomedical FAQs

  • When was Cyfuse Biomedical founded?

    Cyfuse Biomedical was founded in 2010.

  • Where is Cyfuse Biomedical headquartered?

    Cyfuse Biomedical is headquartered in Tokyo, Japan.

  • What is the size of Cyfuse Biomedical?

    Cyfuse Biomedical has 22 total employees.

  • What industry is Cyfuse Biomedical in?

    Cyfuse Biomedical’s primary industry is Discovery Tools (Healthcare).

  • Is Cyfuse Biomedical a private or public company?

    Cyfuse Biomedical is a Public company.

  • What is Cyfuse Biomedical’s stock symbol?

    The ticker symbol for Cyfuse Biomedical is 4892.

  • What is the current stock price of Cyfuse Biomedical?

    As of 15-Jul-2025 the stock price of Cyfuse Biomedical is $4.61.

  • What is the current market cap of Cyfuse Biomedical?

    The current market capitalization of Cyfuse Biomedical is $38.3M.

  • What is Cyfuse Biomedical’s current revenue?

    The trailing twelve month revenue for Cyfuse Biomedical is $360K.

  • Who are Cyfuse Biomedical’s competitors?

    Lonza Group, 3D Biotek, Sutro Biopharma, Teva Pharmaceutical Industries, and Aspect Biosystems are some of the 8 competitors of Cyfuse Biomedical.

  • What is Cyfuse Biomedical’s annual earnings per share (EPS)?

    Cyfuse Biomedical’s EPS for 12 months was -$0.72.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »